United States Biotechnology & Medical Research

Memory Pharmaceuticals Corp (MEMY)

Track

Ticker: MEMY Exchange: NAQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
194.03
Quantity 64,235 +30.5%
Value US$3,954,778
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
61.40
Quantity 69,613 +13.4%
Value US$1,982,840
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
340.34
Quantity 44,297 +24.5%
Value US$3,938,127
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.59
Quantity 527,702 -9.9%
Value US$311,344
FLEMING JONATHAN Non-Executive Director
Transaction date
Purchase
Price
0.55
Quantity 990,066 +38.0%
Value US$544,536
FLEMING JONATHAN Non-Executive Director
Transaction date
Purchase
Price
0.55
Quantity 9,934 +38.0%
Value US$5,464
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.98
Quantity 11,868 -0.3%
Value US$11,631
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.98
Quantity 13,932 -0.3%
Value US$13,653
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
1.02
Quantity 162,840 -3.5%
Value US$166,895
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
1.02
Quantity 191,160 -3.5%
Value US$195,920
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.91
Quantity 108,000 -1.9%
Value US$98,215
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.91
Quantity 92,000 -1.9%
Value US$83,665
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.95
Quantity 191,360 -3.8%
Value US$181,677
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.95
Quantity 224,640 -3.8%
Value US$213,273
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.97
Quantity 41,400 -0.8%
Value US$40,158
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.94
Quantity 353,740 -6.6%
Value US$334,107
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.97
Quantity 48,600 -0.8%
Value US$47,142
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.94
Quantity 415,260 -6.6%
Value US$392,213
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
1.01
Quantity 177,495 -3.2%
Value US$180,051
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
1.11
Quantity 138,000 -2.4%
Value US$153,235
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
1.01
Quantity 208,364 -3.2%
Value US$211,364
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.98
Quantity 162,000 -2.4%
Value US$158,760
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
0.98
Quantity 619,397 -9.8%
Value US$607,009
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
1.10
Quantity 15,686 -0.2%
Value US$17,273
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
1.11
Quantity 727,119 -9.8%
Value US$807,393
GREAT POINT PARTNERS LLC Large shareholder
Transaction date
Sale
Price
1.10
Quantity 18,484 -0.2%
Value US$20,364
MPM BioVentures IV QP LP Large shareholder
Transaction date
Sale
Price
2.10
Quantity 27,600 -0.2%
Value US$57,960
KAILIAN VAUGHN M Non-Executive Director Large shareholder
Transaction date
Sale
Price
2.10
Quantity 27,600 -0.2%
Value US$57,960
KAILIAN VAUGHN M Non-Executive Director Large shareholder
Transaction date
Sale
Price
2.12
Quantity 62,180 -0.4%
Value US$132,120
MPM BioVentures IV QP LP Large shareholder
Transaction date
Sale
Price
2.12
Quantity 62,180 -0.4%
Value US$132,120
KAILIAN VAUGHN M Non-Executive Director Large shareholder
Transaction date
Sale
Price
2.16
Quantity 10,000 -0.1%
Value US$21,611
MPM BioVentures IV QP LP Large shareholder
Transaction date
Sale
Price
2.16
Quantity 10,000 -0.1%
Value US$21,611
KAILIAN VAUGHN M Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.11
Quantity 2,315,151 +25.5%
Value US$2,569,818
MPM BioVentures IV LP Large shareholder
Transaction date
Purchase
Price
1.11
Quantity 2,315,151 +25.5%
Value US$2,569,818
EVNIN ANTHONY B Non-Executive Director
Transaction date
Purchase
Price
1.11
Quantity 516,977 +42.6%
Value US$573,844
EVNIN ANTHONY B Non-Executive Director
Transaction date
Purchase
Price
1.11
Quantity 359,255 +41.8%
Value US$398,773
EVNIN ANTHONY B Non-Executive Director
Transaction date
Purchase
Price
1.11
Quantity 87,623 +47.6%
Value US$97,262
SULAT JAMES R President & CEO Executive Director
Transaction date
Purchase
Price
1.11
Quantity 87,623 +52.2%
Value US$97,262
MEYERS MICHAEL E Non-Executive Director
Transaction date
Purchase
Price
1.11
Quantity 17,525 +66.6%
Value US$19,453
MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
Transaction date
Sale
Price
1.76
Quantity 12,000 -0.3%
Value US$21,140
MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
Transaction date
Sale
Price
1.66
Quantity 3,567 -0.1%
Value US$5,921
MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
Transaction date
Sale
Price
1.78
Quantity 14,300 -0.4%
Value US$25,470
MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
Transaction date
Sale
Price
1.67
Quantity 196,500 -5.0%
Value US$328,587
SULAT JAMES R President & CEO Executive Director
Transaction date
Purchase
Price
1.75
Quantity 10,000 +6.3%
Value US$17,500
MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
Transaction date
Sale
Price
1.86
Quantity 15,600 -0.4%
Value US$29,016
MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
Transaction date
Sale
Price
1.91
Quantity 3,400 -0.1%
Value US$6,496
MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
Transaction date
Sale
Price
2.00
Quantity 14,400 -0.4%
Value US$28,793
MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
Transaction date
Sale
Price
2.02
Quantity 24,000 -0.6%
Value US$48,439
MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
Transaction date
Sale
Price
2.15
Quantity 112,000 -2.7%
Value US$240,509
MARDUEL ALIX No longer a Director
Transaction date
Purchase
Price
0.00
Quantity 789,474
Value US$0
EVNIN ANTHONY B Non-Executive Director
Transaction date
Purchase
Price
1.90
Quantity 465,789 +62.3%
Value US$884,999
EVNIN ANTHONY B Non-Executive Director
Transaction date
Purchase
Price
1.90
Quantity 323,684 +60.4%
Value US$615,000
EVNIN ANTHONY B Non-Executive Director
Transaction date
Purchase
Price
1.90
Quantity 184,211 +inf%
Value US$350,001
SULAT JAMES R President & CEO Executive Director
Transaction date
Purchase
Price
1.90
Quantity 157,895 +inf%
Value US$300,000
FLEMING JONATHAN Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 26,142 +inf%
Value US$49,670
FLEMING JONATHAN Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 2,605,437 +inf%
Value US$4,950,330
FLEMING JONATHAN Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 526,316 +69.5%
Value US$1,000,000
KRIEBEL ROBERT I Non-Executive Director
Transaction date
Purchase
Price
1.90
Quantity 5,000 +inf%
Value US$9,500
MEYERS MICHAEL E Non-Executive Director
Transaction date
Purchase
Price
1.90
Quantity 26,316 +inf%
Value US$50,000
SCULLION TONY President & CEO Executive Director
Transaction date
Purchase
Price
1.90
Quantity 39,474 +28.5%
Value US$75,001
Lowe David A Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
1.90
Quantity 26,316 +inf%
Value US$50,000
GILBERT WALTER PHD Non-Executive Director
Transaction date
Purchase
Price
1.90
Quantity 52,632 +39.5%
Value US$100,001
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.00
Quantity 300 -0.3%
Value US$1,500
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.01
Quantity 8,750 -7.8%
Value US$43,870
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.01
Quantity 8,750 -8.2%
Value US$43,806
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.00
Quantity 8,750 -8.8%
Value US$43,750
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.01
Quantity 8,750 -8.8%
Value US$43,870
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.00
Quantity 8,750 -8.8%
Value US$43,750
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.00
Quantity 8,750 -8.8%
Value US$43,750
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.00
Quantity 2,450 -2.6%
Value US$12,250
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.03
Quantity 6,300 -6.5%
Value US$31,675
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.02
Quantity 8,750 -8.8%
Value US$43,954
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.41
Quantity 4,000 -4.2%
Value US$21,625
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.48
Quantity 4,750 -5.0%
Value US$26,042
SCULLION TONY Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.44
Quantity 1,750 -1.9%
Value US$9,520
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-12-11 2008-12-08 S Sale GREAT POINT PARTNERS LLC Large shareholder
64,235 +30.5%
194.03
US$3,954,778 		64,235 +30.5% 194.03 US$3,954,778
2008-12-11 2008-12-08 S Sale GREAT POINT PARTNERS LLC Large shareholder
69,613 +13.4%
61.40
US$1,982,840 		69,613 +13.4% 61.40 US$1,982,840
2008-12-11 2008-12-05 S Sale GREAT POINT PARTNERS LLC Large shareholder
44,297 +24.5%
340.34
US$3,938,127 		44,297 +24.5% 340.34 US$3,938,127
2008-12-11 2008-12-05 S Sale GREAT POINT PARTNERS LLC Large shareholder
527,702 -9.9%
0.59
US$311,344 		527,702 -9.9% 0.59 US$311,344
2007-11-30 2007-11-28 B Purchase FLEMING JONATHAN Non-Executive Director
990,066 +38.0%
0.55
US$544,536 		990,066 +38.0% 0.55 US$544,536
2007-11-30 2007-11-28 B Purchase FLEMING JONATHAN Non-Executive Director
9,934 +38.0%
0.55
US$5,464 		9,934 +38.0% 0.55 US$5,464
2007-11-06 2007-11-05 S Sale GREAT POINT PARTNERS LLC Large shareholder
11,868 -0.3%
0.98
US$11,631 		11,868 -0.3% 0.98 US$11,631
2007-11-06 2007-11-05 S Sale GREAT POINT PARTNERS LLC Large shareholder
13,932 -0.3%
0.98
US$13,653 		13,932 -0.3% 0.98 US$13,653
2007-11-06 2007-11-02 S Sale GREAT POINT PARTNERS LLC Large shareholder
162,840 -3.5%
1.02
US$166,895 		162,840 -3.5% 1.02 US$166,895
2007-11-06 2007-11-02 S Sale GREAT POINT PARTNERS LLC Large shareholder
191,160 -3.5%
1.02
US$195,920 		191,160 -3.5% 1.02 US$195,920
2007-10-24 2007-10-23 S Sale GREAT POINT PARTNERS LLC Large shareholder
108,000 -1.9%
0.91
US$98,215 		108,000 -1.9% 0.91 US$98,215
2007-10-24 2007-10-22 S Sale GREAT POINT PARTNERS LLC Large shareholder
92,000 -1.9%
0.91
US$83,665 		92,000 -1.9% 0.91 US$83,665
2007-10-24 2007-10-22 S Sale GREAT POINT PARTNERS LLC Large shareholder
191,360 -3.8%
0.95
US$181,677 		191,360 -3.8% 0.95 US$181,677
2007-10-24 2007-10-22 S Sale GREAT POINT PARTNERS LLC Large shareholder
224,640 -3.8%
0.95
US$213,273 		224,640 -3.8% 0.95 US$213,273
2007-10-22 2007-10-17 S Sale GREAT POINT PARTNERS LLC Large shareholder
41,400 -0.8%
0.97
US$40,158 		41,400 -0.8% 0.97 US$40,158
2007-10-22 2007-10-17 S Sale GREAT POINT PARTNERS LLC Large shareholder
353,740 -6.6%
0.94
US$334,107 		353,740 -6.6% 0.94 US$334,107
2007-10-22 2007-10-17 S Sale GREAT POINT PARTNERS LLC Large shareholder
48,600 -0.8%
0.97
US$47,142 		48,600 -0.8% 0.97 US$47,142
2007-10-22 2007-10-17 S Sale GREAT POINT PARTNERS LLC Large shareholder
415,260 -6.6%
0.94
US$392,213 		415,260 -6.6% 0.94 US$392,213
2007-10-17 2007-10-16 S Sale GREAT POINT PARTNERS LLC Large shareholder
177,495 -3.2%
1.01
US$180,051 		177,495 -3.2% 1.01 US$180,051
2007-10-17 2007-10-16 S Sale GREAT POINT PARTNERS LLC Large shareholder
138,000 -2.4%
1.11
US$153,235 		138,000 -2.4% 1.11 US$153,235
2007-10-17 2007-10-16 S Sale GREAT POINT PARTNERS LLC Large shareholder
208,364 -3.2%
1.01
US$211,364 		208,364 -3.2% 1.01 US$211,364
2007-10-17 2007-10-16 S Sale GREAT POINT PARTNERS LLC Large shareholder
162,000 -2.4%
0.98
US$158,760 		162,000 -2.4% 0.98 US$158,760
2007-10-17 2007-10-15 S Sale GREAT POINT PARTNERS LLC Large shareholder
619,397 -9.8%
0.98
US$607,009 		619,397 -9.8% 0.98 US$607,009
2007-10-17 2007-10-15 S Sale GREAT POINT PARTNERS LLC Large shareholder
15,686 -0.2%
1.10
US$17,273 		15,686 -0.2% 1.10 US$17,273
2007-10-17 2007-10-15 S Sale GREAT POINT PARTNERS LLC Large shareholder
727,119 -9.8%
1.11
US$807,393 		727,119 -9.8% 1.11 US$807,393
2007-10-17 2007-10-15 S Sale GREAT POINT PARTNERS LLC Large shareholder
18,484 -0.2%
1.10
US$20,364 		18,484 -0.2% 1.10 US$20,364
2007-09-18 2007-09-14 S Sale MPM BioVentures IV QP LP Large shareholder
27,600 -0.2%
2.10
US$57,960 		27,600 -0.2% 2.10 US$57,960
2007-09-18 2007-09-14 S Sale KAILIAN VAUGHN M Non-Executive Director Large shareholder
27,600 -0.2%
2.10
US$57,960 		27,600 -0.2% 2.10 US$57,960
2007-09-14 2007-09-13 S Sale KAILIAN VAUGHN M Non-Executive Director Large shareholder
62,180 -0.4%
2.12
US$132,120 		62,180 -0.4% 2.12 US$132,120
2007-09-14 2007-09-13 S Sale MPM BioVentures IV QP LP Large shareholder
62,180 -0.4%
2.12
US$132,120 		62,180 -0.4% 2.12 US$132,120
2007-09-14 2007-09-12 S Sale KAILIAN VAUGHN M Non-Executive Director Large shareholder
10,000 -0.1%
2.16
US$21,611 		10,000 -0.1% 2.16 US$21,611
2007-09-14 2007-09-12 S Sale MPM BioVentures IV QP LP Large shareholder
10,000 -0.1%
2.16
US$21,611 		10,000 -0.1% 2.16 US$21,611
2007-01-05 2006-12-18 B Purchase KAILIAN VAUGHN M Non-Executive Director Large shareholder
2,315,151 +25.5%
1.11
US$2,569,818 		2,315,151 +25.5% 1.11 US$2,569,818
2007-01-05 2006-12-18 B Purchase MPM BioVentures IV LP Large shareholder
2,315,151 +25.5%
1.11
US$2,569,818 		2,315,151 +25.5% 1.11 US$2,569,818
2006-10-18 2006-10-16 B Purchase EVNIN ANTHONY B Non-Executive Director
516,977 +42.6%
1.11
US$573,844 		516,977 +42.6% 1.11 US$573,844
2006-10-18 2006-10-16 B Purchase EVNIN ANTHONY B Non-Executive Director
359,255 +41.8%
1.11
US$398,773 		359,255 +41.8% 1.11 US$398,773
2006-10-18 2006-10-16 B Purchase EVNIN ANTHONY B Non-Executive Director
87,623 +47.6%
1.11
US$97,262 		87,623 +47.6% 1.11 US$97,262
2006-10-18 2006-10-16 B Purchase SULAT JAMES R

President & CEO

Executive Director
87,623 +52.2%
1.11
US$97,262 		87,623 +52.2% 1.11 US$97,262
2006-10-18 2006-10-16 B Purchase MEYERS MICHAEL E Non-Executive Director
17,525 +66.6%
1.11
US$19,453 		17,525 +66.6% 1.11 US$19,453
2006-06-12 2006-06-09 S Sale MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
12,000 -0.3%
1.76
US$21,140 		12,000 -0.3% 1.76 US$21,140
2006-06-12 2006-06-08 S Sale MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
3,567 -0.1%
1.66
US$5,921 		3,567 -0.1% 1.66 US$5,921
2006-06-12 2006-06-08 S Sale MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
14,300 -0.4%
1.78
US$25,470 		14,300 -0.4% 1.78 US$25,470
2006-06-12 2006-06-08 S Sale MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
196,500 -5.0%
1.67
US$328,587 		196,500 -5.0% 1.67 US$328,587
2006-06-06 2006-06-05 B Purchase SULAT JAMES R

President & CEO

Executive Director
10,000 +6.3%
1.75
US$17,500 		10,000 +6.3% 1.75 US$17,500
2006-06-05 2006-06-01 S Sale MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
15,600 -0.4%
1.86
US$29,016 		15,600 -0.4% 1.86 US$29,016
2006-06-05 2006-06-01 S Sale MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
3,400 -0.1%
1.91
US$6,496 		3,400 -0.1% 1.91 US$6,496
2006-05-17 2006-05-15 S Sale MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
14,400 -0.4%
2.00
US$28,793 		14,400 -0.4% 2.00 US$28,793
2006-05-15 2006-05-12 S Sale MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
24,000 -0.6%
2.02
US$48,439 		24,000 -0.6% 2.02 US$48,439
2006-05-15 2006-05-11 S Sale MARXE AUSTIN W & GREENHOUSE DAVID M Large shareholder
112,000 -2.7%
2.15
US$240,509 		112,000 -2.7% 2.15 US$240,509
2005-09-27 2005-09-23 B Purchase MARDUEL ALIX

No longer a Director
789,474
0.00
US$0 		789,474 0.00 US$0
2005-09-26 2005-09-23 B Purchase EVNIN ANTHONY B Non-Executive Director
465,789 +62.3%
1.90
US$884,999 		465,789 +62.3% 1.90 US$884,999
2005-09-26 2005-09-23 B Purchase EVNIN ANTHONY B Non-Executive Director
323,684 +60.4%
1.90
US$615,000 		323,684 +60.4% 1.90 US$615,000
2005-09-26 2005-09-23 B Purchase EVNIN ANTHONY B Non-Executive Director
184,211 +inf%
1.90
US$350,001 		184,211 +inf% 1.90 US$350,001
2005-09-23 2005-09-23 B Purchase SULAT JAMES R

President & CEO

Executive Director
157,895 +inf%
1.90
US$300,000 		157,895 +inf% 1.90 US$300,000
2005-09-23 2005-09-23 B Purchase FLEMING JONATHAN Non-Executive Director Large shareholder
26,142 +inf%
1.90
US$49,670 		26,142 +inf% 1.90 US$49,670
2005-09-23 2005-09-23 B Purchase FLEMING JONATHAN Non-Executive Director Large shareholder
2,605,437 +inf%
1.90
US$4,950,330 		2,605,437 +inf% 1.90 US$4,950,330
2005-09-23 2005-09-23 B Purchase FLEMING JONATHAN Non-Executive Director Large shareholder
526,316 +69.5%
1.90
US$1,000,000 		526,316 +69.5% 1.90 US$1,000,000
2005-09-23 2005-09-23 B Purchase KRIEBEL ROBERT I Non-Executive Director
5,000 +inf%
1.90
US$9,500 		5,000 +inf% 1.90 US$9,500
2005-09-23 2005-09-23 B Purchase MEYERS MICHAEL E Non-Executive Director
26,316 +inf%
1.90
US$50,000 		26,316 +inf% 1.90 US$50,000
2005-09-23 2005-09-23 B Purchase SCULLION TONY

President & CEO

Executive Director
39,474 +28.5%
1.90
US$75,001 		39,474 +28.5% 1.90 US$75,001
2005-09-23 2005-09-23 B Purchase Lowe David A

Chief Scientific Officer

Executive Director
26,316 +inf%
1.90
US$50,000 		26,316 +inf% 1.90 US$50,000
2005-09-23 2005-09-23 B Purchase GILBERT WALTER PHD Non-Executive Director
52,632 +39.5%
1.90
US$100,001 		52,632 +39.5% 1.90 US$100,001
2005-03-16 2005-03-14 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
300 -0.3%
5.00
US$1,500 		300 -0.3% 5.00 US$1,500
2005-03-09 2005-03-07 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
8,750 -7.8%
5.01
US$43,870 		8,750 -7.8% 5.01 US$43,870
2005-03-03 2005-03-01 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
8,750 -8.2%
5.01
US$43,806 		8,750 -8.2% 5.01 US$43,806
2005-02-24 2005-02-22 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
8,750 -8.8%
5.00
US$43,750 		8,750 -8.8% 5.00 US$43,750
2005-02-15 2005-02-14 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
8,750 -8.8%
5.01
US$43,870 		8,750 -8.8% 5.01 US$43,870
2005-02-09 2005-02-07 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
8,750 -8.8%
5.00
US$43,750 		8,750 -8.8% 5.00 US$43,750
2005-02-04 2005-02-02 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
8,750 -8.8%
5.00
US$43,750 		8,750 -8.8% 5.00 US$43,750
2005-01-26 2005-01-25 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
2,450 -2.6%
5.00
US$12,250 		2,450 -2.6% 5.00 US$12,250
2005-01-26 2005-01-24 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
6,300 -6.5%
5.03
US$31,675 		6,300 -6.5% 5.03 US$31,675
2005-01-20 2005-01-18 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
8,750 -8.8%
5.02
US$43,954 		8,750 -8.8% 5.02 US$43,954
2005-01-12 2005-01-11 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
4,000 -4.2%
5.41
US$21,625 		4,000 -4.2% 5.41 US$21,625
2005-01-12 2005-01-10 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
4,750 -5.0%
5.48
US$26,042 		4,750 -5.0% 5.48 US$26,042
2005-01-05 2005-01-05 PlS Planned sale SCULLION TONY

Chief Executive Officer

Executive Director
1,750 -1.9%
5.44
US$9,520 		1,750 -1.9% 5.44 US$9,520
Explore more

More insider trading research around Memory Pharmaceuticals Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America